Pharmaceutical Supply – Topical Corticosteroid with Anesthetic

The contract involves the supply of two units of Hydrocortisone Acetate and Pramoxine Hydrochloride, a topical pharmaceutical formulation used for military medical purposes, specifically designed to treat inflammatory skin conditions with associated pain or itching. The product must meet all federal pharmaceutical standards and comply with the logistical and quality control requirements set by the Defense Logistics Agency, ensuring suitability for deployment and use in field medical environments. The contract is classified as a subcontract under NAICS code 424210, indicating it falls within pharmaceutical and bulk drug merchant wholesaling, and is managed by the Department of Defense through its DLA procurement system. Delivery and fulfillment are governed by DLA’s supply chain protocols, with the item designated for military medical use and subject to strict regulatory oversight. The contract was posted on August 2, 2026, and is linked to an active award under contract number SPE2DX25D8022 and delivery order SPE2D926F7844, with the procurement process managed through the DIBBS platform. While specific delivery locations and points of contact are not detailed, the performance is expected to align with DLA’s nationwide distribution network to support operational readiness and medical service personnel across all branches of the armed forces.